Literature DB >> 17404045

IRF-7: new role in the regulation of genes involved in adaptive immunity.

Marco Sgarbanti1, Giulia Marsili, Anna Lisa Remoli, Roberto Orsatti, Angela Battistini.   

Abstract

The interferon regulatory factor 7 (IRF-7), a member of the IRF family of transcription factors, is a key player in the innate immune response against viral infections. Constitutive expression of IRF-7 is limited to peripheral blood lymphocytes and dendritic cells while in most cell types its expression can be induced by type I interferon (INF). IRF-7 is sequestered in the cytoplasm of uninfected cells and following viral infection, double-stranded RNA (dsRNA), or toll-like receptor (TLR) signaling, it becomes phosphorylated by TBK and IKK-i kinases. Phosphorylated IRF-7 migrates in the nucleus where it can activate IFN type I genes and other interferon-stimulated genes (ISGs). Here we report that the overexpression of a constitutively active form of IRF-7 binds and positively regulates the transcriptional activity of the promotor of IRF-1 and low molecular mass polypeptide-2 (LMP-2), two proteins that play a key role in adaptive immunity. The so far unrecognized role of IRF-7 in LMP-2 stimulation points to IRF-7 as a transcriptional regulator that bridges innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404045     DOI: 10.1196/annals.1397.036

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

Review 1.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

2.  Plasma Non-transferrin-Bound Iron Could Enter into Mice Duodenum and Negatively Affect Duodenal Defense Response to Virus and Immune Responses.

Authors:  Xiaonan Yu; Qian Zhang; Haoxuan Ding; Peng Wang; Jie Feng
Journal:  Biol Trace Elem Res       Date:  2022-03-16       Impact factor: 3.738

3.  Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells.

Authors:  Irina L Tourkova; Galina V Shurin; Soldano Ferrone; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2008-08-28       Impact factor: 6.968

4.  Interferon regulatory factor 7 contributes to the control of Leishmania donovani in the mouse liver.

Authors:  Lynette Beattie; Rebecca Phillips; Najmeeyah Brown; Benjamin M J Owens; Neal Chauhan; Jane E Dalton; Paul M Kaye
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

5.  IRF7 regulates TLR2-mediated activation of splenic CD11c(hi) dendritic cells.

Authors:  Benjamin M J Owens; John W J Moore; Paul M Kaye
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

6.  A bioinformatic analysis identifies circadian expression of splicing factors and time-dependent alternative splicing events in the HD-MY-Z cell line.

Authors:  Nikolai Genov; Alireza Basti; Mónica Abreu; Rosario Astaburuaga; Angela Relógio
Journal:  Sci Rep       Date:  2019-07-30       Impact factor: 4.379

7.  Cytokines interleukin-1beta and tumor necrosis factor-alpha regulate different transcriptional and alternative splicing networks in primary beta-cells.

Authors:  Fernanda Ortis; Najib Naamane; Daisy Flamez; Laurence Ladrière; Fabrice Moore; Daniel A Cunha; Maikel L Colli; Thomas Thykjaer; Kasper Thorsen; Torben F Orntoft; Decio L Eizirik
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

8.  Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition.

Authors:  Wendy Mao; Ali Ghasemzadeh; Zachary T Freeman; Aleksandar Obradovic; Matthew G Chaimowitz; Thomas R Nirschl; Emily McKiernan; Srinivasan Yegnasubramanian; Charles G Drake
Journal:  J Immunother Cancer       Date:  2019-10-25       Impact factor: 13.751

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.